Assignee
DEPOMED INC
US32 patents
Top patents by PatentIndex Score
US6488962B1Dec 3, 2002
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
DEPOMED INC442 citations99
US5972389AOct 26, 1999
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
DEPOMED INC456 citations99
US5582837ADec 10, 1996
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
DEPOMED INC314 citations99
US7976870B2Jul 12, 2011
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
DEPOMED INC82 citations98
US6635280B2Oct 21, 2003
Extending the duration of drug release within the stomach during the fed mode
DEPOMED INC282 citations98
US6340475B2Jan 22, 2002
Extending the duration of drug release within the stomach during the fed mode
DEPOMED INC519 citations98
US7438927B2Oct 21, 2008
Methods of treatment using a gastric retained gabapentin dosage
DEPOMED INC56 citations97
US6682759B2Jan 27, 2004
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
DEPOMED INC203 citations97
US6723340B2Apr 20, 2004
Optimal polymer mixtures for gastric retentive tablets
DEPOMED INC299 citations94
US8945619B2Feb 3, 2015
Shell-and-core dosage form approaching zero-order drug release
DEPOMED INC28 citations93
US9566258B2Feb 14, 2017
Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders
DEPOMED INC17 citations92
US8377453B2Feb 19, 2013
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
DEPOMED INC47 citations92
US8043630B2Oct 25, 2011
Shell-and-core dosage form approaching zero-order drug release
DEPOMED INC26 citations92
US7736667B2Jun 15, 2010
Shell-and-core dosage form approaching zero-order drug release
DEPOMED INC26 citations92
US7731989B2Jun 8, 2010
Gastric retained gabapentin dosage form
DEPOMED INC22 citations92
US7612112B2Nov 3, 2009
Methods of treatment using a gastric retained gabapentin dosage
DEPOMED INC20 citations92
US7405238B2Jul 29, 2008
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
DEPOMED INC36 citations92
US8372432B2Feb 12, 2013
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
DEPOMED INC20 citations91
US7413751B2Aug 19, 2008
Methods of treatment using a gastric retained losartan dosage
DEPOMED INC31 citations90
US6451808B1Sep 17, 2002
Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
DEPOMED INC142 citations89
US9937142B2Apr 10, 2018
Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders
DEPOMED INC9 citations84
US9597338B2Mar 21, 2017
Shell-and-core dosage form approaching zero-order drug release
DEPOMED INC9 citations84
US8802157B2Aug 12, 2014
Methods of treatment using a gastric retained gabapentin dosage form
DEPOMED INC7 citations84
US9301934B2Apr 5, 2016
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
DEPOMED INC9 citations83
US9572780B2Feb 21, 2017
Dual drug dosage forms with improved separation of drugs
DEPOMED INC12 citations82
US8999388B2Apr 7, 2015
Dual drug dosage forms with improved separation of drugs
DEPOMED INC11 citations82
US8592481B2Nov 26, 2013
Gastric retentive gabapentin dosage forms and methods for using same
DEPOMED INC8 citations80
US8252332B2Aug 28, 2012
Gastric retained gabapentin dosage form
DEPOMED INC1 citations62
US9801816B2Oct 31, 2017
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
DEPOMED INC1 citations61
US8580303B2Nov 12, 2013
Gastric retained gabapentin dosage form
DEPOMED INC0 citations52
US9561200B2Feb 7, 2017
Method of treating post-surgical acute pain
DEPOMED INC0 citations50
US9814705B2Nov 14, 2017
Intranasal spray device containing pharmaceutical composition
DEPOMED INC0 citations49